NSG BioLabs, a leading provider of biotech co-working laboratory and office space in Singapore, has announced key partnerships and new investments that will further enhance its services and support for biotech startups. Since 2019, NSG BioLabs has nurtured over 40 companies, helping them secure nearly $400 million in funding. The company’s partnerships with Enterprise Singapore and Merck aim to provide resources and expertise for startup R&D efforts.
Additionally, NSG BioLabs has recently secured a strategic investment of $14.5 million led by Celadon Partners and ClavystBio. This funding will be used to expand infrastructure, services, and benefits for residents, as well as to support the growth of the co-working laboratory and office spaces.
The CEO and Founder of NSG BioLabs, Daphne Theo, expressed gratitude for the support from these strategic investors and emphasized the company’s commitment to empowering residents in their innovation efforts. NSG BioLabs has been actively involved in Singapore’s biotech ecosystem, helping startups achieve significant milestones and supporting job creation.
The company’s recent partnerships with Enterprise Singapore and Merck highlight its dedication to fostering collaboration and driving scientific innovation in the biotech industry. NSG BioLabs aims to fast-track the development and commercialization of deep tech solutions, particularly in precision medicine, through these collaborations.
With three sites totaling 35,000 square feet in Biopolis, Singapore, NSG BioLabs is well-positioned to support the growing biotech community in the region. The company’s focus on providing state-of-the-art equipment, world-class expertise, and extensive networks ensures that companies can efficiently execute cutting-edge research and development initiatives.
Through its partnerships and strategic investments, NSG BioLabs is set to enhance its value-add offerings of infrastructure, services, and networks for its growing community of biotech innovators. The company’s commitment to supporting breakthrough science and driving health impact reinforces its position as a key hub for biotech innovation in the region.
For more information about NSG BioLabs and its offerings, visit http://www.nsgbio.com.
SOURCE: NSG BioLabs
[Image source: NSG BioLabs Logo]
Source link
